Table 5.
Subgroup analysis of occurrence of readmission.
| Subgroups | N | HR | 95%CI | P value |
|---|---|---|---|---|
| Total | 1938 | 1.427 | (1.027,1.984) | 0.034 |
| Male | ||||
| 0 | 577 | 0.815 | (0.429,1.549) | 0.532 |
| 1 | 1361 | 1.836 | (1.248,2.700) | 0.002 |
| Vascular occlusion | ||||
| 0 | 1398 | 1.358 | (0.883,2.089) | 0.163 |
| 1 | 540 | 1.426 | (0.835,2.435) | 0.194 |
| Multivessel disease | ||||
| 0 | 165 | 15.011 | (3.484,64.675) | < 0.001 |
| 1 | 1773 | 1.250 | (0.884,1.769) | 0.207 |
| CCB/ARB/ACEI | ||||
| 0 | 757 | 1.250 | (0.667,2.340) | 0.486 |
| 1 | 1181 | 1.533 | (1.036,2.270) | 0.033 |
| Statins | ||||
| 0 | 127 | 1.486 | (0.681,3.246) | 0.320 |
| 1 | 1811 | 1.355 | (0.943,1.946) | 0.100 |
| FPG | ||||
| < 6.1 | 1172 | 1.505 | (0.951,2.381) | 0.081 |
| 6.1–7.0 | 291 | 1.585 | (0.745,3.371) | 0.231 |
| ≥ 7.0 | 475 | 1.122 | (0.601,2.096) | 0.718 |
| LDL-C | ||||
| < 1.8 | 242 | 1.846 | (0.456,7.466) | 0.390 |
| 1.8–2.6 | 682 | 1.400 | (0.558,3.513) | 0.473 |
| ≥ 2.6 | 1014 | 1.878 | (1.232,2.861) | 0.003 |